(NASDAQ:VOR), CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences: Citi's 2025 Biopharma Back to School ConferenceFireside Chat: Tuesday, September 2nd, 2025, at 11:15am ETLocation: Boston, MA A live webcast […]
(NasdaqGM:ESPR), ANN ARBOR, Mich., Aug. 26, 2025 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of September, which can be found on our investor relations website. Cantor Global Healthcare Conference in New York on September 3, 2025, at 9:45 a.m.
AUSTIN, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) — via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The TechMediaWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The
(NASDAQ:INNV), DENVER, Aug. 26, 2025 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2025 fiscal fourth quarter and full year financial
Delray Beach, FL, Aug. 26, 2025 (GLOBE NEWSWIRE) — The Mullings Group Companies (“TMG”), a global leader in talent access for MedTech, HealthTech, and Life Sciences, today announced the official expansion of services with the launch of its Strategic Initiative Service. “For years, we've been delivering these solutions for clients, ranging from startups to mid-cap
(NasdaqGM:ALLR), TARPON SPRINGS, Fla., August 26, 2025 — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib–a differentiated, dual PARP and WNT pathway inhibitor–today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to stenoparib, its investigational treatment for patients
(SWX:HODL),(SWX:ABTC),(SWX:ABCH),(SWX:ABBA),(SWX:KEYS),(SWX:ABNB),(SWX:AETH),(SWX:AXRP),(SWX:AXTZ),(Paris:ABTC),(Paris:AETH),(Paris:SBTC),(Euronext Amsterdam:2BTC),(Euronext Amsterdam:BTCS),(Euronext Amsterdam:2ETH),(SWX:ADOT SE),(SWX:AADA SE),(SWX:AXLM SE),(SWX:SBTC SE),(LSE:ETHC LN),(LSE:CETU LN),(LSE:CBTC LN),(LSE:CBTU LN),(LSE:AETH LN),(LSE:ETHU LN),(LSE:BTCU LN),(LSE:ABTC LN), NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) — 21Shares US LLC today announced the renaming of the 21Shares Ethereum Core ETF (CETH) or “the Fund” to the 21Shares Ethereum ETF (TETH), effective August 28, 2025. The changes do not
VIENNA and LAUSANNE, Switzerland, Aug. 26, 2025 (GLOBE NEWSWIRE) — Proxygen, a global leader in the discovery and development of molecular glue degraders, today announced a strategic research collaboration with EPFL (the Swiss Federal Institute of Technology in Lausanne). The partnership combines Proxygen's validated glue degrader discovery platform with the pioneering work of Professor Bruno
(NASDAQ:TASK), SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, PLLP is investigating whether the board of directors of TaskUs, Inc. (NASDAQ: TASK) breached their fiduciary duties in connection with the proposed sale of the company to Blackstone, TaskUs Co-Founder and CEO Bryce Maddock, and Co-Founder and President Jaspar Weir
Cambridge, MA, Aug. 26, 2025 (GLOBE NEWSWIRE) — CAMBRIDGE, Mass, August 26, 2025 – Organizations face enormous pressure to adapt to shifting customer expectations, emerging technologies, and new competitive threats. But in a recent research report from Deloitte, employees surveyed across organizational hierarchies said they spent roughly half their day (41%) on work that created